Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Magnetic Resonance Imaging in Type 2 Diabetes Mellitus: The Næstved/Slagelse/Ringsted Cohort

NCT05915260 is registered in ClinicalTrials.gov with Slagelse Hospital as lead sponsor.

NCT NCT05915260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05915260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Magnetic Resonance Imaging in Type 2 Diabetes Mellitus: The Næstved/Slagelse/Ringsted Cohort
Lead sponsor
Slagelse Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 1, 2023
Completion date
January 31, 2030
Enrollment
700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular magnetic resonance imaging, coronary microvascular dysfunction, diabetes mellitus, type 2, diabetic cardiomyopathies, myocardium; fibrosis